Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

12 nov. 2025 14h21 HE | Source: Quetzal Therapeutics

Quetzal Therapeutics Appoints Todd Smith as Board Member

Quetzal Therapeutics Appoints Todd Smith as Board Member
16 sept. 2025 12h10 HE | Source: Quetzal Therapeutics

Quetzal Therapeutics Appoints Dr. Shaad Abedin as Chief Medical Officer

Quetzal Therapeutics Appoints Dr. Shaad Abedin as Chief Medical Officer
16 juil. 2025 13h13 HE | Source: Quetzal Therapeutics

Quetzal Therapeutics Debuts with Expert Leadership, High-Impact Pipeline and $50 Million of Committed Capital

Quetzal Therapeutics, a newly formed biopharmaceutical company, announced its official launch today with $50 million of committed capital.